Bath & Body Works, Inc. $BBWI Shares Sold by Lecap Asset Management Ltd.

Key Points

• Lecap Asset Management Ltd. reduced its holdings in Bath & Body Works by 55.3% in the second quarter, owning 47,688 shares worth approximately $1.43 million after selling 58,941 shares.
• The company reported quarterly earnings of $0.37 per share, matching analysts' estimates, with revenue of $1.55 billion, reflecting a 0.8% year-over-year decline.
• A quarterly dividend of $0.20 per share was announced, yielding an annualized rate of 3.1% and a payout ratio of 23.74% as of August 22.

Lecap Asset Management Ltd. decreased its holdings in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 55.3% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 47,688 shares of the company's stock after selling 58,941 shares during the quarter. Lecap Asset Management Ltd.'s holdings in Bath & Body Works were worth $1,429,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Robeco Institutional Asset Management B.V. purchased a new position in shares of Bath & Body Works during the second quarter worth $667,000. TOWER TRUST & INVESTMENT Co grew its holdings in shares of Bath & Body Works by 8.6% during the second quarter. TOWER TRUST & INVESTMENT Co now owns 15,981 shares of the company's stock worth $479,000 after purchasing an additional 1,272 shares during the last quarter. Missouri Trust & Investment Co grew its holdings in shares of Bath & Body Works by 4.2% during the second quarter. Missouri Trust & Investment Co now owns 43,975 shares of the company's stock worth $1,317,000 after buying an additional 1,775 shares during the last quarter. TD Private Client Wealth LLC boosted its holdings in Bath & Body Works by 34.9% in the 2nd quarter. TD Private Client Wealth LLC now owns 4,460 shares of the company's stock valued at $134,000 after purchasing an additional 1,155 shares in the last quarter. Finally, Forte Capital LLC ADV purchased a new stake in Bath & Body Works in the 2nd quarter valued at approximately $218,000. 95.14% of the stock is currently owned by hedge funds and other institutional investors.

Bath & Body Works Stock Performance

BBWI stock opened at $25.66 on Thursday. The company's 50-day simple moving average is $28.65 and its 200 day simple moving average is $29.53. Bath & Body Works, Inc. has a 52 week low of $24.93 and a 52 week high of $41.87. The company has a market capitalization of $5.29 billion, a PE ratio of 7.61, a price-to-earnings-growth ratio of 0.88 and a beta of 1.52.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its quarterly earnings data on Thursday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.37. The firm had revenue of $1.55 billion for the quarter, compared to the consensus estimate of $1.55 billion. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The business's revenue for the quarter was down .8% on a year-over-year basis. During the same period in the prior year, the company posted $0.37 earnings per share. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. On average, analysts forecast that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, September 5th. Shareholders of record on Friday, August 22nd were issued a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 3.1%. The ex-dividend date of this dividend was Friday, August 22nd. Bath & Body Works's payout ratio is presently 23.74%.

Wall Street Analysts Forecast Growth

BBWI has been the subject of several research reports. UBS Group cut their price objective on Bath & Body Works from $36.00 to $32.00 and set a "neutral" rating for the company in a research report on Friday, August 29th. Citigroup dropped their price objective on shares of Bath & Body Works from $42.00 to $40.00 and set a "buy" rating on the stock in a research note on Tuesday, August 19th. Telsey Advisory Group reiterated an "outperform" rating and issued a $38.00 price objective on shares of Bath & Body Works in a report on Thursday, August 28th. Wall Street Zen downgraded shares of Bath & Body Works from a "buy" rating to a "hold" rating in a research report on Saturday, August 9th. Finally, JPMorgan Chase & Co. upped their price target on shares of Bath & Body Works from $40.00 to $46.00 and gave the company an "overweight" rating in a research report on Monday, July 28th. Twelve research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $39.69.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.